APIMEDS PHARMACEUTICALS US, INC. Payments of Debt Issuance Costs
APIMEDS PHARMACEUTICALS US, INC. (APUS) reported Payments of Debt Issuance Costs of $585.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-08-14
- APIMEDS PHARMACEUTICALS US, INC. payments of debt issuance costs for the quarter ending 2026-06-30 was $510.00K.
- APIMEDS PHARMACEUTICALS US, INC. payments of debt issuance costs for the quarter ending 2026-03-31 was $75.00K.
- APIMEDS PHARMACEUTICALS US, INC. payments of debt issuance costs for fiscal 2025 was $946.00K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|
| 2026-06-30 | $510.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $585.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $75.00K 10-Q · filed 2026-05-26 | ||
| 2025-12-31 | $946.00K 10-K · filed 2026-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |